Fig. 6From: Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)Expression of immunotherapy target molecules versus TIS in melanoma. Log2 expression of drug target genes is plotted against TIS scores in the TCGA melanoma datasetBack to article page